KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New virus therapy injected into tumors shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called MQ710, a modified virus injected directly into tumors, for people with advanced solid cancers that have not responded to standard treatments. The study aims to find the safest dose of MQ710 when given alone or with the immunothe…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
Could a cancer pill shrink kaposi tumors?
Disease control Recruiting nowThis study tests a drug called ixazomib in 41 people with Kaposi sarcoma, a type of skin cancer. The drug works by blocking enzymes that help cancer cells grow. The main goal is to see how many people's tumors shrink or disappear.
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
New drug combo aims to unleash immune system on kaposi sarcoma tumors
Disease control Recruiting nowThis study tests two non-chemotherapy drugs, PDS01ADC and M7824, in people with advanced Kaposi sarcoma (KS) that has not responded well to prior treatment. PDS01ADC helps the immune system attack tumors, while M7824 blocks cancer cells' ability to hide. The goal is to see if the…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Blood pressure drug shows promise against rare cancer
Disease control Recruiting nowThis study tests whether propranolol, a safe oral drug used for heart conditions, can shrink Kaposi sarcoma tumors in adults. About 25 participants with measurable skin lesions will receive the drug to see if at least 45% respond. The goal is to find a low-cost, accessible treatm…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a protein boost immune cells and fight cancer in HIV patients?
Disease control Recruiting nowThis study tests a lab-made protein called CYT107 in 55 adults with HIV-related Kaposi sarcoma who have low T-cell counts. The goal is to see if weekly injections for up to 4 weeks can shrink tumors by boosting the immune system. Participants who improve may receive another round…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Could a pill and IV combo tame Virus-Linked cancers?
Disease control Recruiting nowThis early-phase study tests a combination of two drugs—pomalidomide (a pill) and nivolumab (an IV infusion)—in adults with cancers caused by viruses like Epstein-Barr, HPV, or hepatitis. The goal is to find a safe dose and see if the drugs can shrink tumors or slow disease. Part…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Scientists launch Long-Term study to track kaposi Sarcoma's natural course
Knowledge-focused Recruiting nowThis study follows 150 adults with Kaposi sarcoma (KS) to understand how the disease develops, changes, and may come back over time. Researchers will track participants for up to 10 years using exams, scans, and biopsies. The goal is to learn more about KS, not to test a new trea…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 01, 2026 15:24 UTC